This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Pfizer Corporation. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: David Peter Scholfield: Innovator in Medical Treatments
Introduction
David Peter Scholfield is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of medical treatments, particularly in addressing conditions that affect the urinary tract. His innovative approach has led to the development of a patent that aims to improve the quality of life for individuals suffering from specific bladder-related ailments.
Latest Patents
David Peter Scholfield holds a patent for the "Treatment of interstitial cystitis." This invention relates to the use of an anti-NGF antibody in the treatment or prevention of pain and/or lower urinary tract symptoms (LUTS) associated with interstitial cystitis, painful bladder syndrome, and bladder pain syndrome. This patent represents a significant advancement in the therapeutic options available for these challenging conditions.
Career Highlights
David is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development in medical treatments.
Collaborations
Throughout his career, David has worked alongside esteemed colleagues such as Stephen Charles Phillips and Arnon Rosenthal. These collaborations have fostered an environment of innovation and have been instrumental in the advancement of their shared goals in medical research.
Conclusion
David Peter Scholfield's contributions to the field of medical treatments, particularly through his patent for the treatment of interstitial cystitis, highlight his role as an influential inventor. His work continues to impact the lives of many individuals facing urinary tract challenges.